Upperton Pharma Solutions is pleased to announce that the company has relocated to larger, self-contained facilities at Highfields Science Park, adjacent to the University of Nottingham. The move to new premises underlines the company’s rapid expansion and will enable it to develop its own cGMP manufacturing capabilities for early phase clinical trials.
The 15,000 square foot facility will house all of the company’s R&D team, as well as its fast-growing Quality Assurance and Manufacturing departments. Within the building is a clean room suite suitable for cGMP manufacture, and a pilot plant for non-GMP intermediate scale manufacturing. Upperton plans to have an MHRA licence for clinical trials manufacturing by Q3 of 2018.
The relocation and expansion will allow the company to offer a full integrated pharmaceutical development service, from early feasibility studies through to cGMP manufacture to support clinical trials. The extended range of capabilities includes:
- cGMP manufacturing for clinical trials, release testing and QP release
- Range of additional powder handling and filling capabilities
- Enhanced dosage form development service
- Expanded analytical services
To find out more about Upperton Pharma Solutions, please click here.
